A phase III randomized, open label, multicenter study comparing isatuximab, pomalidomide, and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM).

被引：0

作者：

Richardson, Paul G.

Attal, Michel

Rajkumar, S. Vincent

San Miguel, Jesus

Beksac, Meral

Spicka, Ivan

Leleu, Xavier

Schjesvold, Fredrik

Moreau, Philippe

Dimopoulos, Meletios A.

Huang, Jeffrey S. Y.

Minarik, Jiri

Cavo, Michele

Prince, H. Miles

Mace, Sandrine

Corzo, Kathryn Penkus

Campana, Frank

Le-Guennec, Solenn

Dubin, Franck

Anderson, Kenneth Carl

机构：

[1] Harvard Med Sch, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA

[2] IUCT Oncopole, Toulouse, France

[3] Mayo Clin, Rochester, MN USA

[4] Clin Univ Navarra, Navarra, Spain

[5] Ankara Univ, Ankara, Turkey

[6] Vseobecna Fak Nemocnice V Praze, Prague, Czech Republic

[7] CHRU Lille, Lille, France

[8] Oslo Univ Hosp, Oslo, Norway

[9] CHU Nantes, Hotel Dieu, Nantes, France

[10] Univ Athens, Athens, Greece

[11] Natl Taiwan Univ Hosp, Taipei, Taiwan

[12] Univ Hosp Olomouc, Olomouc, Czech Republic

[13] Bologna Univ, Sch Med, Seragnoli Inst Hematol, Bologna, Italy

[14] Epworth Healthcare, Melbourne, Vic, Australia

[15] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[16] Sanofi R&D, Oncol, Vitry Sur Seine, France

[17] Sanofi, Cambridge, MA USA

[18] Sanofi US, Cambridge, MA USA

[19] Sanofi R&D, Vitry Sur Seine, France

[20] Sanofi, Vitry Sur Seine, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8004

引用

页数：2

共 50 条

[21] MM-005: A phase I trial of pomalidomide, bortezomib, and low-dose dexamethasone (PVD) in relapsed and/or refractory multiple myeloma (RRMM)
Richardson, Paul Gerard Guy
Hofmeister, Craig C.
Siegel, David Samuel DiCapua
Lonial, Sagar
Laubach, Jacob
Efebera, Yvonne Adeduni
Vesole, David H.
Nooka, Ajay K.
Rosenblatt, Jacalyn
Raje, Noopur S.
Zaki, Mohamed H.
Hua, Ye
Shah, Sheetal
Wang, Jianming
Anderson, Kenneth Carl
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[22] Safety Results of a Phase 2 Multicenter, Open-Label Study of Pomalidomide (CC-4047) Plus Low-Dose Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment
Weisel, Katja
Dimopoulos, Meletios A.
van de Donk, Niels W. C. J.
Ramasamy, Karthik
Gamberi, Barbara
Streetly, Matthew
Offidani, Massimo
Bridoux, Frank
de la Rubia, Javier
Kueenburg, Elisabeth
Lersch, Frederik
Rosettani, Barbara
Bacon, Pamela
Sonneveld, Pieter
BLOOD, 2016, 128 (22)
[23] Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Impact of Renal Function on Patient Outcomes
Siegel, David S.
Richardson, Paul G.
Baz, Rachid
Chen, Min
Zaki, Mohamed
Anderson, Kenneth C.
BLOOD, 2012, 120 (21)
[24] Pomalidomide (POM) with Low-Dose Dexamethasone (LoDEX) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Outcomes Based on Prior Treatment Exposure
Vij, Ravi
Hofmeister, Craig C.
Richardson, Paul G.
Jagannath, Sundar
Siegel, David S.
Baz, Rachid
Chen, Min
Zaki, Mohamed
Larkins, Gail
Anderson, Kenneth C.
BLOOD, 2012, 120 (21)
[25] Analysis of renal impairment in MM-003, a phase III study of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in refractory or relapsed and refractory multiple myeloma
Weisel, Katja C.
Dimopoulos, Meletios A.
Moreau, Philippe
Lacy, Martha Q.
Song, Kevin W.
Delforge, Michel
Karlin, Lionel
Goldschmidt, Hartmut
Banos, Anne
Oriol, Albert
Alegre, Adrian
Chen, Christine
Cavo, Michele
Garderet, Laurent
Ivanova, Valentina
Martinez-Lopez, Joaquin
Knop, Stefan
Yu, Xin
Hong, Kevin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed H.
Miguel, Jesus San
HAEMATOLOGICA, 2016, 101 (07) : 872 - 878
[26] Immune Profiling of Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide and Low-Dose Dexamethasone in Combination with Daratumumab
Pierceall, William E.
Bahlis, Nizar
Siegel, David S.
Schiller, Gary J.
Samaras, Christy J.
Sebag, Michael
Berdeja, Jesus G.
Ganguly, Siddhartha
Matous, Jeffrey V.
Song, Kevin
Seet, Christopher S.
Talamo, Giampaolo
Srinivas, Shanti
Acosta-Rivera, Mirelis
Bar, Michael
Quick, Donald P.
Anz, Bertrand
Fonseca, Gustavo
Reece, Donna
Chung, Weiyuan
Serbina, Natalya
Zafar, Faiza
Agarwal, Amit
Thakurta, Anjan
BLOOD, 2018, 132
[27] Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure
Siegel, David S.
Schiller, Gary J.
Song, Kevin W.
Agajanian, Richy
Stockerl-Goldstein, Keith
Kaya, Hakan
Sebag, Michael
Samaras, Christy
Malek, Ehsan
Talamo, Giampaolo
Seet, Christopher S.
Mouro, Jorge
Pierceall, William E.
Zafar, Faiza
Chung, Weiyuan
Srinivasan, Shankar
Agarwal, Amit
Bahlis, Nizar J.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 501 - 510
[28] MM-011: A Phase 2 Study of Pomalidomide Plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma in Japan
Hagiwara, Shotaro
Okamoto, Shinichiro
Matsue, Kosei
Iida, Shinsuke
Sunami, Kazutaka
Komeno, Takuya
Suzuki, Kenshi
Ando, Kiyoshi
Taniwaki, Masafumi
Tobinai, Kensei
Chou, Takaaki
Kaneko, Hitomi
Iwasaki, Hiromi
Uemura, Chie
Tamakoshi, Hiromi
Zaki, Mohamed H.
Doerr, Thomas
Kuroda, Yoshiaki
Ichinohe, Tatsuo
BLOOD, 2015, 126 (23)
[29] A PHASE 2 MULTICENTER STUDY OF POMALIDOMIDE IN COMBINATION WITH LOW-DOSE DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: THE MM-011 TRIAL
Hagiwara, S.
Okamoto, S.
Matsue, K.
Iida, S.
Sunami, K.
Komeno, T.
Suzuki, K.
Ando, K.
Taniwaki, M.
Tobinai, K.
Chou, T.
Kaneko, H.
Iwasaki, H.
Uemura, C.
Tamakoshi, H.
Zaki, M. H.
Doerr, T.
Kuroda, Y.
Ichinohe, T.
HAEMATOLOGICA, 2016, 101 : 790 - 790
[30] MM-013 PHASE 2 MULTICENTER STUDY OF POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT
Sonneveld, P.
Weisel, K.
van de Donk, N.
Ramasamy, K.
Gamberi, B.
Streetly, M.
Offidani, M.
Bridoux, F.
de la Rubia, J.
Kueenburg, E.
Collins, S.
Di Micco, A.
Rosettani, B.
Bacon, P.
Dimopoulos, M.
HAEMATOLOGICA, 2017, 102 : 113 - 114

← 1 2 3 4 5 →